News & Updates

Show Multimedia Only
Statins confer some protection against breast cancer recurrence in Asians

Statins confer some protection against breast cancer recurrence in Asians

04 May 2022 byJairia Dela Cruz

Taking a statin after breast cancer surgery appears to reduce the risk of disease recurrence in Asians, especially among those with invasive cancers, as shown in a study from Singapore.

04 May 2022
Brigatinib a potential standard treatment alternative for treatment-naive ALK+ NSCLC

Brigatinib a potential standard treatment alternative for treatment-naive ALK+ NSCLC

30 Apr 2022 byAudrey Abella

In patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer (ALK+ NSCLC) who were ALK inhibitor-naïve, brigatinib showed superior efficacy and safety over crizotinib, according to the final results of the phase III ALTA-1L* trial presented at ELCC 2022.

30 Apr 2022